Evaluation of risks related to the use of adeno-associated virus-based vectors.

Current gene therapy

Volumn 3, Issue 6, 2003, Pages 545-565

  Tenenbaum, L ^a   Lehtonen, E ^a   Monahan, P E ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO ASSOCIATED VIRUS; ANIMAL; ANTIBODY PRODUCTION; CELLULAR IMMUNITY; GENE VECTOR; GENETIC RECOMBINATION; GENETICS; PHYSIOLOGY; REVIEW; RISK ASSESSMENT; TRANSGENE; VIRUS LATENCY;

ANIMALS; ANTIBODY FORMATION; DEPENDOVIRUS; GENETIC VECTORS; IMMUNITY, CELLULAR; RECOMBINATION, GENETIC; RISK ASSESSMENT; TRANSGENES; VIRUS LATENCY;

EID: 2142751261     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/1566523034578131     Document Type: Review

References (222)